Growth of new bone guided by implants in a murine calvarial model

Bone

Volumn 43, Issue 4, 2008, Pages 781-788

  Freilich, Martin ^a   M Patel, Chirag ^a   Wei, Mei ^b   Shafer, David ^a   Schleier, Peter ^c   Hortschansky, Peter ^d   Kompali, Raji ^b   Kuhn, Liisa ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Clinic for Special Medicine   (Norway)

^d HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Dental implant; Hydroxyapatite; Murine calvaria; Non glycosylated rhBMP 2; Supracrestal bone formation; Titanium

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; TITANIUM; UNCLASSIFIED DRUG;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE GROWTH; CALVARIA; CONTROLLED STUDY; DISEASE MODEL; ELECTRONICS; HISTOPATHOLOGY; IMPLANT; MALE; MATERIAL COATING; MOUSE; NONHUMAN; PERIODONTAL DISEASE; PROTEIN GLYCOSYLATION; TOOTH IMPLANTATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DENTAL IMPLANTS; DURAPATITE; HUMANS; MICE; MODELS, ANIMAL; OSTEOGENESIS; RECOMBINANT PROTEINS; SKULL; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 50949133639     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.05.021     Document Type: Article

References (39)

1. Shibuya T.Y., Wadhwa A., Nguyen K.H., Panossian A.M., Kim S., Wong H., Feinberg S., Damisah E.C., Camilon P.R., and Bang H. Linking of bone morphogenetic protein-2 to resorbable fracture plates for enhancing bone healing. Laryngoscope 115 12 (2005) 2232-2237
2. Mogi G., Fujiyoshi T., Kurono Y., and Kawauchi H. Latissimus dorsi myocutaneous-iliac bone flap for reconstruction of massive defects of mandible and oral basis. Laryngoscope 96 2 (1986) 171-177
3. Jovanovic S., Schenk R., Orsini M., and Kenney E. Supracrestal bone formation around dental implants: an experimental dog study. Int J Oral Maxillofac Implants 10 (1995) 23-31
4. Roos-Jansaker A., Franke-Stenport V., Renvert S., Albrektsson T., and Claffey N. Dog model for study of supracrestal bone apposition around partially inserted implants. Clin Oral Impl Res 13 (2002) 455-459
5. Franke-Stenport V., Roos-Jansaker A., Renvert S., Kuboki Y., Irwin C., Albrektsson T., and Claffey N. Failure to induce supracrestal bone growth between and around partially inserted titanium implants using bone morphogenetic protein (BMP): an experimental study in dogs. Clin Oral Impl Res 14 (2003) 219-225
6. Simion M., Trisi P., and Piattelli A. Vertical ridge augmentation using a membrane technique associated with osseointegrated implants. Int J Periodont Rest Dent 14 (1994) 497-511
7. Sigurdsson T., Fu E., Tatakis D., Rohrer M., and Wikesjo U. Bone morphogenetic protein-2 for peri implant bone regeneration and osseointegration. Clin Oral Impl Res 8 (1997) 367-374
8. Schmitt J.M., Hwang K., Winn S.R., and Hollinger J.O. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17 2 (1999) 269-278
9. Becker J., Kirsch A., Schwarz F., Chatzinikolaidou M., Rothamel D., Lekovic V., Laub M., and Jennissen H.P. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin Oral Investig 10 3 (2006) 217-224
10. Jones A.A., Buser D., Schenk R., Wozney J., and Cochran D.L. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 77 7 (2006) 1184-1193
11. Cochran D.L., Schenk R., Buser D., Wozney J.M., and Jones A.A. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 70 2 (1999) 139-150
12. Cochran D.L., Nummikoski P.V., Jones A.A., Makins S.R., Turek T.J., and Buser D. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 12 6 (1997) 739-748
13. Wikesjö U.M., Qahash M., Thomson R.C., Cook A.D., Rohrer M.D., Wozney J.M., and Hardwick W.R. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 15 2 (2004) 194-204
14. Hanisch O., Sorensen R.G., Kinoshita A., Spiekermann H., Wozney J.M., and Wikesjö U.M. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J Periodontol 74 5 (2003) 648-657
15. Barboza E.P., Duarte M.E., Geolás L., Sorensen R.G., Riedel G.E., and Wikesjö U.M. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 71 3 (2000) 488-496
16. Hunt D.R., Jovanovic S.A., Wikesjö U.M., Wozney J.M., and Bernard G.W. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J Periodontol 72 5 (2001) 651-658
17. Wikesjö U.M., Qahash M., Thomson R.C., Cook A.D., Rohrer M.D., Wozney J.M., and Hardwick W.R. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 5 2 (2003) 112-123
18. Hanisch O., Tatakis D.N., Boskovic M.M., Rohrer M.D., and Wikesjö U.M. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 12 5 (1997) 604-610
19. Liu Y., Enggist L., Kuffer A.F., Buser D., and Hunziker E.B. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 28 (2007) 2677-2686
20. Cole B.J., Bostrom M.P.G., Pritchard T.L., Sumner D.R., Tomin E., Lane J.M., and Weiland A.J. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 345 (1997) 219-228
21. Schmidmaier G., Wildemann B., Cromme F., Kandziora F., Haas N.P., and Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone 30 6 (2002) 816-822
22. Vehof J.W., Mahmood J., Takita H., van't Hof M.A., Kuboki Y., Spauwen P.H., and Jansen J.A. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. Plast Reconstr Surg 108 2 (2001) 434-443
23. Liu Y., de Groot K., and Hunziker E.B. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 36 5 (2005) 745-757
24. Hall J., Sorensen R.G., Wozney J.M., and Wikesjö U.M. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol 34 5 (2007) 444-451
25. Rengachary S.S. Bone morphogenetic proteins: basic concepts. Neurosurg Focus 13 6 (2002) e2
26. Seeherman H., Wozney J., and Li R. Bone morphogenetic protein delivery systems. Spine 27 Suppl 1 (2002) 16-23
27. Kirker-Head C.A. Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev 43 (2000) 65-92
28. Horisaka Y., Okamoto Y., Matsumoto N., Yoshimura Y., Kawada J., Yamashita K., and Takagi T. Subperiosteal implantation of bone morphogenetic protein adsorbed to hydroxyapatite. Clin Orthop Relat Res. 268 (1991) 303-312
29. Ducheyne P., Hench L., Kagan II A., Martens M., Bursens A., and Mulier J. Effect of hydroxyapatite impregnation on skeletal bonding of porous coated implants. J Biomedical Mater Res 14 (1980) 225-237
30. Hench L.L. Bioceramics: from concept to clinic. J Amer Ceramic Society 74 (1991) 1487-1510
31. Geesink R.G., de Groot K., and Klein C.P. Chemical implant fixation using hydroxyl-apatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res 225 (1987) 147-170
32. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17 1 (1996) 31-35
33. Sachse A., Wagner A., Keller M., Wagner O., Wetzel W.D., Layher F., Venbrocks R.A., Hortschansky P., Pietraszczyk M., Wiederanders B., Hempel H.J., Bossert J., Horn J., Schmuck K., and Mollenhauer J. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37 (2005) 699-710
34. Sampath T.K., Coughlin J.E., Whetstone R.M., Banach D., Corbett C., Ridge R.J., et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2a, two members of the transforming growth factor-beta superfamily. J Biol Chem 265 (1990) 13198-13205
35. Schmoekel H.G., Schense J.C., Weber F.E., Graetz K.W., Gnaegi D., Mueller R., and Hubbell J.A. Healing of critical size defects in the rat and the dog with nonglycosylated rhBMP-2 with enhanced retention in fibrin ingrowth matrices. J Orthop Res 22 (2004) 376-381
36. Poynton A.R., and Lane J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 16 Suppl 1 (2002) S40-S48
37. Wei M., Ruys A.J., Swain M.V., Milthorpe B.K., and Sorrell C.C. Hydroxyapatite-coated metals: interfacial reactions during sintering. J Mater Sci Mater Med 16 (2005) 101-106
38. Kothapalli C., Wei M., Vasiliev A., and Shaw M.T. Effect of concentration and temperature on HA morphology. Acta Mater 52 (2004) 5655-5663
39. Groeneveld E.H., and Burger E.H. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142 1 (2000) 9-21